Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Orthopaedic Surgery and Research
Published in: Journal of Orthopaedic Surgery and Research 1/2024

Open Access 01-12-2024 | Osteoporosis | Systematic Review

The effects of resveratrol in animal models of primary osteoporosis: a systematic review and meta-analysis

Authors: Rongxian An, Qian Luo, Lei Li, Dinglu Cui, Jingchun Jin

Published in: Journal of Orthopaedic Surgery and Research | Issue 1/2024

Login to get access

Abstract

Background

There is still a lack of sufficient evidence-based medical data on the effect of resveratrol (Res) on primary osteoporosis (OP). This meta-analysis aimed to comprehensively evaluate the role of Res in animal models of primary OP.

Methods

The PubMed, Cochrane Library, Web of Science and Embase databases were searched up to August 2023. The risk of bias was assessed by the SYRCLE RoB tool. Random- or fixed-effects models were used to determine the 90% confidence interval (CI) or standardized mean difference (SMD). Statistical analysis was performed with RevMan 5.4 and Stata 14.0.

Results

A total of 24 studies containing 714 individuals were included. Compared with those in the control group, the bone mineral density (BMD) (P < 0.00001), bone volume/total volume (BV/TV) (P < 0.001), trabecular thickness (Tb.Th) (P < 0.00001), and trabecular number (Tb.N) (P < 0.00001) were markedly greater, and the trabecular separation (Tb.Sp) (P < 0.00001) was significantly greater. Compared with the control group, the Res group also exhibited marked decreases in alkaline phosphatase (ALP) (P < 0.05), tartrate-resistant acid phosphatase 5b (TRAP5b) (P < 0.01), and type I collagen strong carboxyl peptide (CTX-1) (P < 0.00001) and a marked increase in osteoprotegerin (OPG) (P < 0.00001).

Conclusion

In summary, we concluded that Res can markedly increase BMD, improve morphometric indices of trabecular microstructure and serum bone turnover markers (BTMs), and exert a protective effect in animal models of primary osteoporosis. This study can supply experimental reference for Res in primary osteoporosis treatment.
Appendix
Available only for authorised users
Literature
1.
Liang H, Xiong C, Luo Y, Zhang J, Huang Y, Zhao R, et al. Association between serum polyunsaturated fatty acids and bone mineral density in US adults: NHANES 2011–2014. Front Endocrinol (Lausanne). 2023;14:1266329.PubMedCrossRef
2.
Yang Y, Liu Z, Wu J, Bao S, Wang Y, Li J, et al. Nrf2 mitigates RANKL and M-CSF induced osteoclast differentiation via ROS-dependent mechanisms. Antioxidants (Basel). 2023;12(12):2094.PubMedPubMedCentralCrossRef
3.
Orsini LS, Rousculp MD, Long SR, Wang S. Health care utilization and expenditures in the United States: a study of osteoporosis-related fractures. Osteoporos Int. 2005;16(4):359–71.PubMedCrossRef
4.
Roche JJ, Wenn RT, Sahota O, Moran CG. Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study. BMJ. 2005;331(7529):1374.PubMedPubMedCentralCrossRef
5.
Migliorini F, Colarossi G, Eschweiler J, Oliva F, Driessen A, Maffulli N. Antiresorptive treatments for corticosteroid-induced osteoporosis: a Bayesian network meta-analysis. Br Med Bull. 2022;143(1):46–56.PubMedPubMedCentralCrossRef
6.
Migliorini F, Maffulli N, Colarossi G, Eschweiler J, Tingart M, Betsch M. Effect of drugs on bone mineral density in postmenopausal osteoporosis: a Bayesian network meta-analysis. J Orthop Surg Res. 2021;16(1):533.PubMedPubMedCentralCrossRef
7.
Migliorini F, Giorgino R, Hildebrand F, Spiezia F, Peretti GM, Alessandri-Bonetti M, et al. Fragility fractures: risk factors and management in the elderly. Medicina (Kaunas). 2021;57(10):1119.PubMedCrossRef
8.
Migliorini F, Colarossi G, Baroncini A, Eschweiler J, Tingart M, Maffulli N. Pharmacological management of postmenopausal osteoporosis: a level I evidence based - expert opinion. Expert Rev Clin Pharmacol. 2021;14(1):105–19.PubMedCrossRef
9.
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288(3):321–33.PubMedCrossRef
10.
Baolin L, Inami Y, Tanaka H, Inagaki N, Iinuma M, Nagai H. Resveratrol inhibits the release of mediators from bone marrow-derived mouse mast cells in vitro. Planta Med. 2004;70(4):305–9.PubMedCrossRef
11.
Dai Z, Li Y, Quarles LD, Song T, Pan W, Zhou H, et al. Resveratrol enhances proliferation and osteoblastic differentiation in human mesenchymal stem cells via ER-dependent ERK1/2 activation. Phytomedicine. 2007;14(12):806–14.PubMedCrossRef
12.
Knutson MD, Leeuwenburgh C. Resveratrol and novel potent activators of SIRT1: effects on aging and age-related diseases. Nutr Rev. 2008;66(10):591–6.PubMedCrossRef
13.
Novakovic R, Ilic B, Beleslin-Cokic B, Radunovic N, Heinle H, Scepanovic R, et al. The effect of resveratrol on contractility of non-pregnant rat uterus: the contribution of K(+) channels. J Physiol Pharmacol. 2013;64(6):795–805.PubMed
14.
Boissy P, Andersen TL, Abdallah BM, Kassem M, Plesner T, Delaissé JM. Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation. Cancer Res. 2005;65(21):9943–52.PubMedCrossRef
15.
Lee AM, Shandala T, Nguyen L, Muhlhausler BS, Chen KM, Howe PR, et al. Effects of resveratrol supplementation on bone growth in young rats and microarchitecture and remodeling in ageing rats. Nutrients. 2014;6(12):5871–87.PubMedPubMedCentralCrossRef
16.
Picard F, Kurtev M, Chung N, Topark-Ngarm A, Senawong T, Machado De Oliveira R, et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature. 2004;429(6993):771–6.PubMedPubMedCentralCrossRefADS
17.
Liu ZP, Li WX, Yu B, Huang J, Sun J, Huo JS, et al. Effects of trans-resveratrol from Polygonum cuspidatum on bone loss using the ovariectomized rat model. J Med Food. 2005;8(1):14–9.PubMedCrossRef
18.
Mizutani K, Ikeda K, Kawai Y, Yamori Y. Resveratrol attenuates ovariectomy-induced hypertension and bone loss in stroke-prone spontaneously hypertensive rats. J Nutr Sci Vitaminol (Tokyo). 2000;46(2):78–83.PubMedCrossRef
19.
Zhao H, Li X, Li N, Liu T, Liu J, Li Z, et al. Long-term resveratrol treatment prevents ovariectomy-induced osteopenia in rats without hyperplastic effects on the uterus. Br J Nutr. 2014;111(5):836–46.PubMedCrossRef
20.
Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE’s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14:43.PubMedPubMedCentralCrossRef
21.
Ameen O, Yassien RI, Naguib YM. Activation of FoxO1/SIRT1/RANKL/OPG pathway may underlie the therapeutic effects of resveratrol on aging-dependent male osteoporosis. BMC Musculoskelet Disord. 2020;21(1):375.PubMedPubMedCentralCrossRef
22.
Basem H, Elesawy HFS, Amr M. Synergistic protective effects of resveratrol and estradiol on estrogen deficiency-induced osteoporosis through attenuating RANK pathway. Int J Pharmacol. 2021;4:217–28.
23.
Chen XH, Shi ZG, Lin HB, Wu F, Zheng F, Wu CF, et al. Resveratrol alleviates osteoporosis through improving the osteogenic differentiation of bone marrow mesenchymal stem cells. Eur Rev Med Pharmacol Sci. 2019;23(14):6352–9.PubMed
24.
Elseweidy MM, El-Swefy SE, Shaheen MA, Baraka NM, Hammad SK. Effect of resveratrol and mesenchymal stem cell monotherapy and combined treatment in management of osteoporosis in ovariectomized rats: role of SIRT1/FOXO3a and Wnt/β-catenin pathways. Arch Biochem Biophys. 2021;703: 108856.PubMedCrossRef
25.
Feng J, Liu S, Ma S, Zhao J, Zhang W, Qi W, et al. Protective effects of resveratrol on postmenopausal osteoporosis: regulation of SIRT1-NF-κB signaling pathway. Acta Biochim Biophys Sin (Shanghai). 2014;46(12):1024–33.PubMedCrossRef
26.
Feng YL, Jiang XT, Ma FF, Han J, Tang XL. Resveratrol prevents osteoporosis by upregulating FoxO1 transcriptional activity. Int J Mol Med. 2018;41(1):202–12.PubMed
27.
Jiang Y, Luo W, Wang B, Wang X, Gong P, Xiong Y. Resveratrol promotes osteogenesis via activating SIRT1/FoxO1 pathway in osteoporosis mice. Life Sci. 2020;246: 117422.PubMedCrossRef
28.
Khera A, Kanta P, Kalra J, Dumir D, M T. Resveratrol restores the level of key inflammatory cytokines and RANKL/OPG ratio in the femur of rat osteoporosis model. J Women Aging. 2019;31(6):540–52.PubMedCrossRef
29.
30.
Ozturk S, Cuneyit I, Altuntas F, Karagur ER, Donmez AC, Ocak M, et al. Resveratrol prevents ovariectomy-induced bone quality deterioration by improving the microarchitectural and biophysicochemical properties of bone. J Bone Miner Metab. 2023;41(4):443–56.PubMedCrossRef
31.
Sakr HF, Ammar B, AlKharusi A, Al-Lawati I, AlKhateeb M, Elesawy BH. Resveratrol modulates bone mineral density and bone mineral content in a rat model of male hypogonadism. Chin J Integr Med. 2023;29(2):146–54.PubMedCrossRef
32.
Sehmisch S, Hammer F, Christoffel J, Seidlova-Wuttke D, Tezval M, Wuttke W, et al. Comparison of the phytohormones genistein, resveratrol and 8-prenylnaringenin as agents for preventing osteoporosis. Planta Med. 2008;74(8):794–801.PubMedCrossRef
33.
Tresguerres IF, Tamimi F, Eimar H, Barralet J, Torres J, Blanco L, et al. Resveratrol as anti-aging therapy for age-related bone loss. Rejuvenation Res. 2014;17(5):439–45.PubMedCrossRef
34.
Wang W, Zhang LM, Guo C, Han JF. Resveratrol promotes osteoblastic differentiation in a rat model of postmenopausal osteoporosis by regulating autophagy. Nutr Metab (Lond). 2020;17:29.PubMedCrossRef
35.
Wang X, Lu C, Chen Y, Wang Q, Bao X, Zhang Z, et al. Resveratrol promotes bone mass in ovariectomized rats and the SIRT1 rs7896005 SNP is associated with bone mass in women during perimenopause and early postmenopause. Climacteric. 2023;26(1):25–33.PubMedCrossRef
36.
Wei L, Chai S, Yue C, Zhang H, Li J, Qin N. Resveratrol protects osteocytes against oxidative stress in ovariectomized rats through AMPK/JNK1-dependent pathway leading to promotion of autophagy and inhibition of apoptosis. Cell Death Discov. 2023;9(1):16.PubMedPubMedCentralCrossRef
37.
Yuquan Shi CK, Li Y. Resveratrol inhibits osteoporosis in mice model. Mater Express. 2022;12:939–47.CrossRef
38.
Zamai RS, Corrêa MG, Ribeiro FV, Cirano FR, Casati MZ, Messora MR, et al. Does resveratrol favor peri-implant bone repair in rats with ovariectomy-induced osteoporosis? Gene expression, counter-torque and micro-CT analysis. Braz Oral Res. 2023;37: e003.PubMedCrossRef
39.
Zhang Y, Deng L, Fan J, Zhang Y. Effects of resveratrol on bone metabolism and bone turnover related indexes in ovariectomized osteoporosis rats. Cell Mol Biol Noisy-le-grand. 2020;66(5):92–7.PubMedCrossRef
40.
Zhang Y, Liu MW, He Y, Deng N, Chen Y, Huang J, et al. Protective effect of resveratrol on estrogen deficiency-induced osteoporosis though attenuating NADPH oxidase 4/nuclear factor kappa B pathway by increasing miR-92b-3p expression. Int J Immunopathol Pharmacol. 2020;34:2058738420941762.PubMedPubMedCentralCrossRef
41.
Zuozhong Liu CS, Huang L, Yiming Qu. Resveratrol facilitates bone marrow mesenchymal stem cells (BMSCs) differentiation to prevent osteoporosis via restraining of secreted frizzled-related protein 1 expression. Mater Express. 2021;11(10):1636–44.CrossRef
42.
Mizutani K, Ikeda K, Kawai Y, Yamori Y. Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells. Biochem Biophys Res Commun. 1998;253(3):859–63.PubMedCrossRef
43.
Li YTZM, Deng YJ, Zhu XY, Cheng GF. Expression of interleukin-6 in delayed type hypersensitivity and inhibition ef fects of resveratrol on interleukin-6 biosynthesis Yao Hsueh Hsueh Pao. ACTA PHARMACEUTICA SINICA. 1999;34:189–91.
44.
Conti V, Russomanno G, Corbi G, Toro G, Simeon V, Filippelli W, et al. A polymorphism at the translation start site of the vitamin D receptor gene is associated with the response to anti-osteoporotic therapy in postmenopausal women from southern Italy. Int J Mol Sci. 2015;16(3):5452–66.PubMedPubMedCentralCrossRef
45.
Migliorini F, Maffulli N, Spiezia F, Tingart M, Maria PG, Riccardo G. Biomarkers as therapy monitoring for postmenopausal osteoporosis: a systematic review. J Orthop Surg Res. 2021;16(1):318.PubMedPubMedCentralCrossRef
46.
Migliorini F, Maffulli N, Spiezia F, Peretti GM, Tingart M, Giorgino R. Potential of biomarkers during pharmacological therapy setting for postmenopausal osteoporosis: a systematic review. J Orthop Surg Res. 2021;16(1):351.PubMedPubMedCentralCrossRef
Metadata
Title
The effects of resveratrol in animal models of primary osteoporosis: a systematic review and meta-analysis
Authors
Rongxian An
Qian Luo
Lei Li
Dinglu Cui
Jingchun Jin
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Journal of Orthopaedic Surgery and Research / Issue 1/2024
Electronic ISSN: 1749-799X
DOI
https://doi.org/10.1186/s13018-024-04595-1

Other articles of this Issue 1/2024

Journal of Orthopaedic Surgery and Research 1/2024 Go to the issue

Research article

Study on the mechanism of action of Wu Mei Pill in inhibiting rheumatoid arthritis through TLR4-NF-κB pathway

Research article

Total knee arthroplasty following lateral closing-wedge high tibial osteotomy versus primary total knee arthroplasty: a propensity score matching study

Research article

Arabic version of the SF‐Qualiveen: cross-cultural adaptation, translation, and validation of urinary disorder‐specific instruments in patients with spinal cord injury

Correction

Correction: Changes of improvement in upper limb function predict surgical outcome after laminoplasty in 1 year in patients with cervical spondylotic myelopathy: a retrospective study

Research article

Comparative study on the technique and efficacy of microscope-assisted MI-TLIF and naked-eye MI-TLIF in lumbar revision surgery

Research article

Clinical efficacy analysis of surgical treatment for spinal metastasis under the multidisciplinary team using the NOMS decision system combined with the revised Tokuhashi scoring system: a randomized controlled study